chordoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Dana-Farber Cancer Institute (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadchordoma

I am/have/hadmeasurable disease

I am/have/hadsarcoma

I am/have/hadrenal function

I am/have/hadkarnofsky performance status

I am/have/haddyspnea at rest

I am/have/hadmyelosuppressive chemotherapy

I am/have/hadhcg pregnancy test

I am/have/hadneutrophil count

I am/have/hadserum lipase

I am/have/hadpulse oximetry

I am/have/hadlipase

I am/have/hadepithelioid sarcoma

I am/have/hadbiological therapy

I am/have/hadcancer treatment

I am/have/hadrhabdoid tumor

I am/have/hadblood transfusion

I am/have/hadkidney function tests

I am/have/hadimmunohistochemistry

added new label for I am/have/had

more

I am looking for

I am looking fornivolumab

I am looking formonoclonal antibodies

I am looking forsmall molecule

I am looking formonoclonal protein

I am looking foripilimumab

I am looking forbiologics

I am looking forlipase

I am looking forsamarium

I am looking forgrowth factor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

This clinical trial is studying two immunotherapy drugs (nivolumab and ipilimumab) given together as a possible treatment for INI1-negative tumors.

dyspnea at rest

small molecule

monoclonal protein

hcg pregnancy test

neutrophil count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.